CTS reported third-quarter 2026 sales of $149.6 million, up 5% from a year earlier, and diluted EPS of $0.61 versus $0.46. It raised its 2026 guidance, lifting the sales range to $580-$590 million from $565-$585 million and the adjusted diluted EPS range to $2.78-$2.88 from $2.55-$2.70. Reported third-quarter results include a $12.5 million insurance recovery that the company excludes from its adjusted figures.
Q3 2026 sales were $149.6 million, up 5%; diluted EPS was $0.61 versus $0.46, and adjusted diluted EPS was $0.77 versus $0.60.
2026 sales guidance raised to $580-$590 million from $565-$585 million.
2026 adjusted diluted EPS guidance raised to $2.78-$2.88 from $2.55-$2.70.
Q3 2026 results include a $12.5 million insurance recovery, which the company excludes from adjusted EBITDA and adjusted EPS.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From CTS Corporation's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$541.32M
+5.2%
$2.19
+21.0%
12.1%
FY2024
$514.76M
-6.5%
$1.81
-5.7%
10.8%
FY2023
$550.42M
-6.2%
$1.92
+3.8%
11.0%
FY2022
$586.87M
+14.4%
$1.85
—
10.2%
FY2021
$512.92M
+21.0%
$-1.30
-222.6%
-8.2%
Frequently asked questions
When is CTS's next earnings date?
CTS has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did CTS earn last quarter?
For the quarter ended Sep 2026, CTS reported diluted EPS of $0.61 (+32.6% year over year) on revenue of $149.58M (+4.6%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.